317 related articles for article (PubMed ID: 22647456)
1. Effect of silymarin on bladder overactivity in cyclophosphamide-induced cystitis rat model.
Eser N; Göçmen C; Erdoğan S; Büyüknacar HS; Kumcu EK; Açıkalın A; Önder S
Phytomedicine; 2012 Jun; 19(8-9):840-5. PubMed ID: 22647456
[TBL] [Abstract][Full Text] [Related]
2. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
[TBL] [Abstract][Full Text] [Related]
3. Effect of phosphodiesterase type 4 inhibitor rolipram on cyclophosphamide-induced cystitis in rats.
Büyüknacar HS; Kumcu EK; Göçmen C; Onder S
Eur J Pharmacol; 2008 May; 586(1-3):293-9. PubMed ID: 18358472
[TBL] [Abstract][Full Text] [Related]
4. Effect of hyaluronic acid on urine nerve growth factor in cyclophosphamide-induced cystitis.
Ho DR; Chen CS; Lin WY; Chang PJ; Huang YC
Int J Urol; 2011 Jul; 18(7):525-31. PubMed ID: 21605172
[TBL] [Abstract][Full Text] [Related]
5. Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder.
Juszczak K; Ziomber A; Wyczółkowski M; Thor PJ
Can J Physiol Pharmacol; 2010 Sep; 88(9):899-906. PubMed ID: 20921976
[TBL] [Abstract][Full Text] [Related]
6. Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats.
Wróbel A; Doboszewska U; Rechberger E; Rojek K; Serefko A; Poleszak E; Skalicka-Woźniak K; Dudka J; Wlaź P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):613-619. PubMed ID: 28220212
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and urodynamic effects of a potent and selective EP4 receptor antagonist, MF191, on cyclophosphamide and prostaglandin E2-induced bladder overactivity in rats.
Chuang YC; Tyagi P; Huang CC; Chancellor MB; Yoshimura N
BJU Int; 2012 Nov; 110(10):1558-64. PubMed ID: 22452546
[TBL] [Abstract][Full Text] [Related]
8. Functional, histological structure and mastocytes alterations in rat urinary bladders following acute and [corrected] chronic cyclophosphamide treatment.
Juszczak K; Gil K; Wyczolkowski M; Thor PJ
J Physiol Pharmacol; 2010 Aug; 61(4):477-82. PubMed ID: 20814076
[TBL] [Abstract][Full Text] [Related]
9. Effects of vitamin D analog on bladder function and sensory signaling in animal models of cystitis.
Shapiro B; Redman TL; Zvara P
Urology; 2013 Feb; 81(2):466.e1-7. PubMed ID: 23374845
[TBL] [Abstract][Full Text] [Related]
10. Involvement of orexin-A on micturition reflex in normal and cyclophosphamide-induced cystitis bladder in rat.
Kobayashi M; Nomura M; Fujihara H; Suzuki H; Otsubo H; Nishii H; Fujimoto N; Matsumoto T; Ueta Y
Peptides; 2009 Dec; 30(12):2348-56. PubMed ID: 19666069
[TBL] [Abstract][Full Text] [Related]
11. Improvement by phytotherapeutic agent of detrusor overactivity, down-regulation of pharmacological receptors and urinary cytokines in rats with cyclophosphamide induced cystitis.
Nasrin S; Masuda E; Kugaya H; Ito Y; Yamada S
J Urol; 2013 Mar; 189(3):1123-9. PubMed ID: 23000860
[TBL] [Abstract][Full Text] [Related]
12. Effect of tramadol on pain-related behaviors and bladder overactivity in rodent cystitis models.
Oyama T; Homan T; Kyotani J; Oka M
Eur J Pharmacol; 2012 Feb; 676(1-3):75-80. PubMed ID: 22197002
[TBL] [Abstract][Full Text] [Related]
13. Effect of the rho-kinase inhibitor hydroxyfasudil on bladder overactivity: an experimental rat model.
Masago T; Watanabe T; Saito M; Kinoshita Y; Sato K; Miyagawa I
Int J Urol; 2009 Oct; 16(10):842-7. PubMed ID: 19735460
[TBL] [Abstract][Full Text] [Related]
14. GRC-6211, a new oral specific TRPV1 antagonist, decreases bladder overactivity and noxious bladder input in cystitis animal models.
Charrua A; Cruz CD; Narayanan S; Gharat L; Gullapalli S; Cruz F; Avelino A
J Urol; 2009 Jan; 181(1):379-86. PubMed ID: 19010489
[TBL] [Abstract][Full Text] [Related]
15. Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats.
Chuang YC; Yoshimura N; Huang CC; Wu M; Chiang PH; Chancellor MB
Eur Urol; 2009 Jul; 56(1):159-66. PubMed ID: 18514386
[TBL] [Abstract][Full Text] [Related]
16. Animal models of overactive bladder: cyclophosphamide (CYP)-induced cystitis in rats.
Juszczak K; Królczyk G; Filipek M; Dobrowolski ZF; Thor PJ
Folia Med Cracov; 2007; 48(1-4):113-23. PubMed ID: 19051698
[TBL] [Abstract][Full Text] [Related]
17. Activation of the adenosine A1 receptor in the lumbosacral spinal cord improves bladder overactivity in rats with cystitis induced by cyclophosphamide.
Zhang L; Chen X; Li M; Lv R; Gu B; Chen Z
Int Urol Nephrol; 2023 Sep; 55(9):2183-2191. PubMed ID: 37330931
[TBL] [Abstract][Full Text] [Related]
18. Effects of low energy shock wave therapy on inflammatory moleculars, bladder pain, and bladder function in a rat cystitis model.
Wang HJ; Lee WC; Tyagi P; Huang CC; Chuang YC
Neurourol Urodyn; 2017 Aug; 36(6):1440-1447. PubMed ID: 28035695
[TBL] [Abstract][Full Text] [Related]
19. JTS-653 blocks afferent nerve firing and attenuates bladder overactivity without affecting normal voiding function.
Kitagawa Y; Wada M; Kanehisa T; Miyai A; Usui K; Maekawa M; Sakata M; Matsuo A; Hayashi M; Matsushita M
J Urol; 2013 Mar; 189(3):1137-46. PubMed ID: 22999996
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis.
Ozawa H; Chancellor MB; Jung SY; Yokoyama T; Fraser MO; Yu Y; de Groat WC; Yoshimura N
J Urol; 1999 Dec; 162(6):2211-6. PubMed ID: 10569621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
